Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 227 of 6351
-
New hope for stiff lungs? drug trial targets scarring from autoimmune disease
Disease control Recruiting nowInterstitial lung disease (ILD) is a lung condition resulting in inflammation and stiffening of the lung, often associated with connective tissue diseases (CTDs). ILD causes reduction in lung volume, shortness of breath, cough and fatigue therefore has high impact on quality of l…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for pancreatic cancer: four-drug combo tested in phase 2 trial
Disease control Recruiting nowPancreatic cancer is a kind of digestive system tumor with high malignant degree and poor prognosis. Most patients with pancreatic cancer are locally advanced or have distant metastases at the time of diagnosis, so it is extremely important to find effective drugs to control tumo…
Phase 2 • Sponsor: Liu Xiufeng • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Magic mushroom compound may quiet the depressed Brain's endless Self-Criticism
Symptom relief Recruiting nowThis open-label functional Magnetic Resonance Imaging (fMRI) study will assess the effects of a single dose of psilocybin on rumination and the neural correlates of rumination in individuals with major depressive disorder.
Phase 3 • Sponsor: Sharmin Ghaznavi • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can allergy shots quiet the sneezing and stuffy nose caused by dust mites?
Disease control CompletedRationale: Allergic rhinitis/rhinoconjunctivitis (ARC) is a global health problem, affecting 10-25% of the population. Allergen-specific immunotherapy is the only disease-modifying therapeutic option for subjects with house dust mites (HDM)-induced allergic rhinitis/rhinoconjunct…
Phase 3 • Sponsor: HAL Allergy • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a second diuretic boost recovery from heart failure?
Disease control Recruiting nowAim to identify the best strategy for treating acute heart failure (AHF) with volume overload, particularly focusing on patients resistant to standard loop-diuretics. The trial is a double-blinded, randomized, controlled, multicenter study. Its primary objective is to compare the…
Phase 4 • Sponsor: Johannes Grand • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Cholera vaccine ring strategy tested in bangladesh hotspots
Prevention Recruiting nowTo evaluate the effectiveness of the CATI approach among household contacts in the reduction of cumulative incidence of cholera and explore the genome analysis and immune response of V. cholerae antigen from different hotspots in Dhaka city, cholera cases will be enrolled by rapi…
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Could a Microbiota-Targeted food strengthen immunity in malnourished kids?
Disease control CompletedThe goal of this study is to evaluate the efficacy of microbiota-directed food in comparison to zinc with micronutrient powder and Khichuri on changes in circulating immune cells (monocytes, T cells, B cells, and NK cells) in malnourished children after recovery from acute infect…
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a simple tablet test and AI catch dementia years earlier?
Diagnosis By invitation onlyThe goal of this observational trial is to leverage the electronic Self-Administered Gerocognitive Examination (eSAGE), a variety of metadata (a set of data that describes and gives information about other data) collected during eSAGE testing, electronic health records (EHR) info…
Sponsor: Douglas Scharre • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Can a new targeted pill boost chemotherapy against a tough lung cancer?
Disease control Recruiting nowThis is a multicenter, open Phase II clinical study to evaluate the efficacy, safety, and pharmacokinetic characteristics of BEBT-109 combined with injectable pemetrexed disodium and carboplatin or cisplatin injection as first-line treatment for locally advanced, recurrent, or me…
Phase 2 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo aims to boost CAR-T power against stubborn lymphoma
Disease control Recruiting nowThis is a phase 2, open-label, randomized, multicenter clinical trial in patients with relapsed/refractory mantle cell lymphoma (R/R MCL) who meet the criteria for standard-of-care FDA label for CD19 CAR T-cell therapy with brexucabtagene autoleucel (brexu-cel).
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Magnetic pulses to the brain may tame Parkinson's drug side effects
Disease control Recruiting nowThe proposed study investigates the use of repetitive transcranial magnetic stimulation (rTMS) as a treatment for levodopa-induced dyskinesia (LID) in Parkinson's Disease (PD). Specifically, the study aims to determine whether patterned stimulation of the pre-supplementary motor …
Sponsor: Danish Research Centre for Magnetic Resonance • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Lung surgery without a breathing tube: a gentler path to recovery?
Disease control CompletedThis research focuses on a Health Technology Assessment (HTA) of non-intubated video-assisted thoracic surgery (VATS) for lung nodules. Lung cancer, one of the most prevalent malignancies globally, has a high incidence and mortality rate, particularly in China. Traditional treatm…
Sponsor: Fudan University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can targeted brain zaps restore arm movement after stroke?
Disease control Recruiting nowUpper limb hemiparesis is the most common sequelae in patients, severely impacting their independence and quality of life. Transcranial electrical stimulation (tCES) is a non-invasive and safe treatment, which uses a low direct current or alternating current to change the excitab…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a Two-Drug combo shrink BRCA-Linked breast tumors?
Disease control Recruiting nowThis research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) in Breast Cancer 1/2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study …
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for bile duct cancer: targeted therapy duo takes on standard chemo
Disease control Recruiting nowThe purpose of this study is to measure the efficacy and safety of T-DXd with rilvegostomig or T-DXd monotherapy compared with gemcitabine plus cisplatin and durvalumab in patients with advanced treatment naïve HER2-expressing BTC.
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Robots vs. therapists: a head-to-head trial for stroke recovery
Disease control Recruiting nowRehabilitation after stroke often employs Robot and Allied Digital Technologies (RADTs), yet evidence on their effectiveness remains inconclusive due to study heterogeneity and limited sample sizes. This multicentre randomized controlled pragmatic trial aims at comprehensively a…
Sponsor: Fondazione Don Carlo Gnocchi ETS • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a new drug target HER2-Positive tumors that resist standard care?
Disease control Stopped earlyThis is an open-label, randomized, multi-center phase II study to evaluate the safety, tolerability, PK, and efficacy of SHR-4602 monotherapy in subjects with HER2-expressing or -mutated unresectable or metastatic solid tumors. During the study, a safety monitoring committee (SM…
Phase 2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a tiny heart implant fix a leaky valve without surgery?
Disease control OngoingThis study is prospective, non-randomized, single-arm,first in human study to evaluate the safety and feasibility of the Versa Vascular System for intervention in adults with severe tricuspid regurgitation who are not surgical candidates.
Sponsor: Versa Vascular, Inc • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug combo aims to control tough leukemia
Disease control Recruiting nowTo learn if the combination of blinatumomab and asciminib can help to control Ph+ ALL.
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a Two-Pronged immune attack beat head and neck cancer?
Disease control OngoingThe administration of first-line pembrolizumab monotherapy or combined chemotherapy has been shown to improve survival among patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC). However, over 80% of the patients still experience disease progres…
Phase 2 • Sponsor: West China Hospital • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC